| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | CIGNA CORPORATION | 33,000 | 4,834,000 | 0.64% | ||
| 52 | CERNER CORP | 74,500 | 4,384,000 | 0.58% | ||
| 53 | NEKTAR THERAPEUTICS COM | 172,000 | 4,036,000 | 0.54% | ||
| 54 | GENMARK DIAGNOSTICS INC. | 312,666 | 4,008,000 | 0.53% | ||
| 55 | COOPER COS INC | 20,000 | 3,998,000 | 0.53% | ||
| 56 | JOHNSON & JOHNSON | 31,500 | 3,923,000 | 0.52% | ||
| 57 | HUMANA INC | 19,000 | 3,917,000 | 0.52% | ||
| 58 | COHERUS BIOSCIENCES INC COM | 175,000 | 3,701,000 | 0.49% | ||
| 59 | MCKESSON CORP | 24,000 | 3,558,000 | 0.47% | ||
| 60 | ISHARES TR | 12,000 | 3,519,000 | 0.47% | ||
| 61 | HALOZYME THERAPEUTICS INC | 270,000 | 3,499,000 | 0.47% | ||
| 62 | EXPRESS SCRIPTS HLDG CO | 49,500 | 3,263,000 | 0.43% | ||
| 63 | LivaNova PLC | 64,189 | 3,146,000 | 0.42% | ||
| 64 | DEXCOM INC | 36,100 | 3,059,000 | 0.41% | ||
| 65 | NEUROCRINE BIOSCIE COM USD0.001 | 68,000 | 2,944,000 | 0.39% | ||
| 66 | ULTRAGENYX PHARMACEUTICAL INC COM | 42,000 | 2,847,000 | 0.38% | ||
| 67 | DENTSPLY SIRONA INC | 45,000 | 2,810,000 | 0.37% | ||
| 68 | BLUEBIRD BIO INC COM | 29,000 | 2,636,000 | 0.35% | ||
| 69 | AGIOS PHARMACEUTICALS INC | 45,000 | 2,628,000 | 0.35% | ||
| 70 | CVS HEALTH CORP | 33,400 | 2,622,000 | 0.35% | ||
| 71 | TESARO INCORPORATED | 16,000 | 2,462,000 | 0.33% | ||
| 72 | SEATTLE GENETICS INC | 39,000 | 2,452,000 | 0.33% | ||
| 73 | NUVASIVE INC | 31,304 | 2,338,000 | 0.31% | ||
| 74 | ALKERMES PLC | 39,500 | 2,311,000 | 0.31% | ||
| 75 | QIAGEN NV | 79,444 | 2,302,000 | 0.31% | ||
| 76 | PROTHENA CORP PLC | 41,000 | 2,287,000 | 0.30% | ||
| 77 | MASIMO CORP | 23,000 | 2,145,000 | 0.29% | ||
| 78 | THERMO FISHER SCIENTIFIC INC | 13,000 | 1,997,000 | 0.27% | ||
| 79 | AURIS MED HLDG AG | 2,169,625 | 1,996,000 | 0.27% | ||
| 80 | HCA HOLDINGS INC | 21,300 | 1,896,000 | 0.25% | ||
| 81 | LABORATORY CORP AMER HLDGS | 13,000 | 1,865,000 | 0.25% | ||
| 82 | ANGIODYNAMICS INC | 101,700 | 1,765,000 | 0.24% | ||
| 83 | MERCK & CO INC | 27,500 | 1,747,000 | 0.23% | ||
| 84 | Intersect ENT Inc | 100,000 | 1,715,000 | 0.23% | ||
| 85 | PFIZER INC | 50,000 | 1,711,000 | 0.23% | ||
| 86 | CARDINAL HEALTH INC | 20,000 | 1,631,000 | 0.22% | ||
| 87 | ACADIA PHARMACEUTICALS INC COM | 45,000 | 1,547,000 | 0.21% | ||
| 88 | RADIUS HEALTH INCORPORATED COM NEW | 36,500 | 1,411,000 | 0.19% | ||
| 89 | PORTOLA PHARMACEUTICALS INC | 36,000 | 1,411,000 | 0.19% | ||
| 90 | ENDO INTL PLC | 115,000 | 1,283,000 | 0.17% | ||
| 91 | TELEFLEX INC | 6,500 | 1,259,000 | 0.17% | ||
| 92 | BRISTOL MYERS SQUIBB CO | 23,000 | 1,251,000 | 0.17% | ||
| 93 | BIOVERATIV INC | 22,750 | 1,239,000 | 0.17% | ||
| 94 | ZELTIQ AESTHETICS INC | 22,000 | 1,223,000 | 0.16% | ||
| 95 | GLOBUS MED INC | 40,000 | 1,185,000 | 0.16% | ||
| 96 | CLOVIS ONCOLOGY INC | 18,500 | 1,178,000 | 0.16% | ||
| 97 | NOVADAQ TECHNOLOGIES INC | 150,000 | 1,169,000 | 0.16% | ||
| 98 | Esperion Therapeutics Inc | 32,000 | 1,130,000 | 0.15% | ||
| 99 | EXELIXIS INC | 52,000 | 1,127,000 | 0.15% | ||
| 100 | KITE PHARMA INCORPORATED | 14,000 | 1,099,000 | 0.15% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-004497, filed 2017.05.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
